Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Committee hears proposal to cover self‑measured blood‑pressure monitoring for Medicaid recipients, emphasizing maternal health benefits
Loading...
Summary
House Bill 553 would require Maryland Medical Assistance to cover validated home blood‑pressure monitors and related support services for eligible recipients, including pregnant and postpartum individuals; sponsors and clinicians said home monitoring could detect hypertensive disorders earlier and reduce maternal mortality disparities.
Delegate F. Averas presented House Bill 553, a proposal to extend Maryland Medical Assistance coverage to validated self‑measured blood‑pressure monitors and supporting services for eligible recipients, including pregnant and postpartum individuals and people with chronic conditions.
Supporters described the proposal as a practical step to detect and manage hypertensive disorders of pregnancy and chronic hypertension earlier. Kristen Galtney of Total Healthcare noted that 8%–16% of pregnant people experience high blood pressure during pregnancy and that about 24% of pregnancy‑related deaths in Maryland occur between 7 and 42 days postpartum — a window in which many new mothers have no clinical contact other than a single six‑week postpartum visit. "Providing coverage for self measured blood pressure monitoring provides additional support for pregnant and postpartum Medicaid recipients who are at a greater risk for a life of negative health outcomes caused by unmanaged high blood pressure," Galtney said.
Researchers with Johns Hopkins described program experience pairing validated monitors with community health worker support and clinical follow‑up. Dr. Yvonne Commodore‑Mensah, a cardiovascular epidemiologist, said monitoring plus coaching and pharmacist support improved adherence and clinical management in community programs. The sponsor and witnesses argued the policy could reduce severe maternal morbidity and mortality and help address racial disparities in maternal outcomes.
Committee members asked about a Department of Health information letter and suggested technical amendments. The sponsor said she accepted two DOH amendments intended to clarify device definitions and to remove an education mandate; that change, she said, would remove a large fiscal item from the department’s fiscal estimate. The committee did not vote on the bill that day.
Ending: Witnesses urged the committee to approve Medicaid coverage for home blood‑pressure monitors and wraparound support, arguing early detection can avert severe complications and reduce disparities in maternal health; technical and fiscal details remained subject to amendment and negotiation.
